CARLY ASOLAS: Open Payments
NPI 1780337907 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,528 in 130 payments from 20 companies in 2025. Trend: 2023 $2,211 · 2024 $1,530 · 2025 $2,528
Food & beverage: $2,528
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $571 |
| ABBVIE INC. | 33 | $544 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $341 |
| Ardelyx, Inc. | 7 | $180 |
| Aimmune Therapeutics, Inc. | 18 | $160 |
| GENZYME CORPORATION | 7 | $160 |
| Lilly USA, LLC | 6 | $116 |
| Madrigal Pharmaceuticals | 2 | $76 |
| Novo Nordisk Inc | 3 | $69 |
| PFIZER INC. | 3 | $57 |
Products named: TREMFYA, ENTYVIO, RINVOQ, IBSRELA, DUPIXENT, ZENPEP, CREON, OMVOH.
Industry payments across AZ — which companies pay providers there.
